“The hormonal changes throughout the female cycle can be observed or tracked using different biomarkers, leading to the four main types of FABMs that patients may choose: calendar-based methods, cervical fluid methods, sympto-thermal methods, and sympto-hormonal methods.”
“Proov Complete aims to accurately and sensitively predict ovarian reserve and fertile days, and confirm whether ovulation was successful.”
“FABMs provide women with significant control over their family-planning decisions, enabling them to time pregnancies to unique family situations.”
“With technology advancing and FABMs growing in popularity, it is vital to have reliable apps, consistent tracking, and accurate data analysis to interpret the information, particularly for new FABM users and medical professionals without previous FABM training.”
“Within the first 2 years of OCP use, women had a 79% increased rate of depression compared to never users. In adolescents, this rate was even higher, at 95%.”
“Testosterone should be avoided in the treatment of male infertility, [as] exogenous testosterone inhibits production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), further preventing spermatogenesis.”
“A woman with functional hypothalamic amenorrhea (FHA) experiences chronic anovulation without an identifiable organic cause, with the condition often linked to stress, weight changes, undernutrition or excessive exercise.”
Research indicates the optimal window of opportunity for estrogen replacement therapy (ERT) in women is early in the endocrine aging process, during perimenopause and early post-menopause. Initiating ERT at that time may help prevent age-related cognitive decline and decrease the risk of dementia
“To prepare for lactation, breasts require a change and development within the glandular tissue. This process relies on estrogen, progesterone, and prolactin.”
“During the initial stages of menopause, while a woman’s estrogen receptors are still sensitive to estrogen, estrogen replacement has been shown to help prevent neurocognitive decline, Alzheimer’s disease, and Parkinson’s disease.”